Length of stay and economic consequences with rivaroxaban...

Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program

Bookhart, Brahim K., Haskell, Lloyd, Bamber, Luke, Wang, Maria, Schein, Jeff, Mody, Samir H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696998.2014.946993
Date:
October, 2014
File:
PDF, 124 KB
english, 2014
Conversion to is in progress
Conversion to is failed